S&P 500   4,655.27 (+1.32%)
DOW   35,135.94 (+0.68%)
QQQ   399.69 (+2.17%)
AAPL   160.24 (+2.19%)
MSFT   336.63 (+2.11%)
FB   338.03 (+1.47%)
GOOGL   2,910.61 (+2.35%)
AMZN   3,561.57 (+1.63%)
TSLA   1,136.99 (+5.09%)
NVDA   333.76 (+5.95%)
BABA   131.61 (-1.30%)
NIO   40.46 (+1.18%)
CGC   11.06 (-5.39%)
AMD   161.91 (+4.59%)
GE   98.40 (+0.57%)
MU   86.14 (+3.26%)
T   23.89 (-1.36%)
F   19.67 (-0.41%)
DIS   147.81 (-0.20%)
ACB   6.44 (-5.15%)
AMC   36.84 (-2.10%)
PFE   52.40 (-2.96%)
BA   198.50 (-0.36%)
S&P 500   4,655.27 (+1.32%)
DOW   35,135.94 (+0.68%)
QQQ   399.69 (+2.17%)
AAPL   160.24 (+2.19%)
MSFT   336.63 (+2.11%)
FB   338.03 (+1.47%)
GOOGL   2,910.61 (+2.35%)
AMZN   3,561.57 (+1.63%)
TSLA   1,136.99 (+5.09%)
NVDA   333.76 (+5.95%)
BABA   131.61 (-1.30%)
NIO   40.46 (+1.18%)
CGC   11.06 (-5.39%)
AMD   161.91 (+4.59%)
GE   98.40 (+0.57%)
MU   86.14 (+3.26%)
T   23.89 (-1.36%)
F   19.67 (-0.41%)
DIS   147.81 (-0.20%)
ACB   6.44 (-5.15%)
AMC   36.84 (-2.10%)
PFE   52.40 (-2.96%)
BA   198.50 (-0.36%)
S&P 500   4,655.27 (+1.32%)
DOW   35,135.94 (+0.68%)
QQQ   399.69 (+2.17%)
AAPL   160.24 (+2.19%)
MSFT   336.63 (+2.11%)
FB   338.03 (+1.47%)
GOOGL   2,910.61 (+2.35%)
AMZN   3,561.57 (+1.63%)
TSLA   1,136.99 (+5.09%)
NVDA   333.76 (+5.95%)
BABA   131.61 (-1.30%)
NIO   40.46 (+1.18%)
CGC   11.06 (-5.39%)
AMD   161.91 (+4.59%)
GE   98.40 (+0.57%)
MU   86.14 (+3.26%)
T   23.89 (-1.36%)
F   19.67 (-0.41%)
DIS   147.81 (-0.20%)
ACB   6.44 (-5.15%)
AMC   36.84 (-2.10%)
PFE   52.40 (-2.96%)
BA   198.50 (-0.36%)
S&P 500   4,655.27 (+1.32%)
DOW   35,135.94 (+0.68%)
QQQ   399.69 (+2.17%)
AAPL   160.24 (+2.19%)
MSFT   336.63 (+2.11%)
FB   338.03 (+1.47%)
GOOGL   2,910.61 (+2.35%)
AMZN   3,561.57 (+1.63%)
TSLA   1,136.99 (+5.09%)
NVDA   333.76 (+5.95%)
BABA   131.61 (-1.30%)
NIO   40.46 (+1.18%)
CGC   11.06 (-5.39%)
AMD   161.91 (+4.59%)
GE   98.40 (+0.57%)
MU   86.14 (+3.26%)
T   23.89 (-1.36%)
F   19.67 (-0.41%)
DIS   147.81 (-0.20%)
ACB   6.44 (-5.15%)
AMC   36.84 (-2.10%)
PFE   52.40 (-2.96%)
BA   198.50 (-0.36%)
NASDAQ:THRN

Thorne Healthtech Stock Forecast, Price & News

$8.39
-0.09 (-1.06%)
(As of 11/29/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.24
$8.75
50-Day Range
$7.58
$10.00
52-Week Range
$7.38
$10.13
Volume
116,496 shs
Average Volume
207,769 shs
Market Capitalization
$440.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive THRN News and Ratings via Email

Sign-up to receive the latest news and ratings for Thorne Healthtech and its competitors with MarketBeat's FREE daily newsletter.


Thorne Healthtech logo

About Thorne Healthtech

Thorne HealthTech is involved in developing solutions for a personalized approach to health and wellbeing. It provides personalized solutions to consumers, health professionals and corporations. The company's integrated brand includes Thorne and Onegevity. Thorne HealthTech is based in NEW YORK.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:THRN
Phone
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$440.85 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/10/2021
Today
11/29/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/09/2022

MarketRank

Overall MarketRank

2.08 out of 5 stars

Medical Sector

517th out of 1,392 stocks

Pharmaceutical Preparations Industry

241st out of 670 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -












Thorne Healthtech (NASDAQ:THRN) Frequently Asked Questions

Is Thorne Healthtech a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thorne Healthtech in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Thorne Healthtech stock.
View analyst ratings for Thorne Healthtech
or view top-rated stocks.

When is Thorne Healthtech's next earnings date?

Thorne Healthtech is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Thorne Healthtech
.

How were Thorne Healthtech's earnings last quarter?

Thorne Healthtech Inc (NASDAQ:THRN) issued its quarterly earnings results on Wednesday, November, 10th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.02) by $0.03. The company earned $48.01 million during the quarter.
View Thorne Healthtech's earnings history
.

What price target have analysts set for THRN?

4 Wall Street analysts have issued 12 month target prices for Thorne Healthtech's stock. Their forecasts range from $11.00 to $13.00. On average, they anticipate Thorne Healthtech's stock price to reach $11.50 in the next year. This suggests a possible upside of 37.1% from the stock's current price.
View analysts' price targets for Thorne Healthtech
or view top-rated stocks among Wall Street analysts.

When did Thorne Healthtech IPO?

(THRN) raised $98 million in an IPO on Thursday, September 23rd 2021. The company issued 7,000,000 shares at a price of $13.00-$15.00 per share.

What is Thorne Healthtech's stock symbol?

Thorne Healthtech trades on the NASDAQ under the ticker symbol "THRN."

When did the company's quiet period expire?

Thorne Healthtech's quiet period expired on Tuesday, November 2nd. Thorne Healthtech had issued 7,000,000 shares in its IPO on September 23rd. The total size of the offering was $70,000,000 based on an initial share price of $10.00. During the company's quiet period, underwriters and any insiders involved in the IPO were prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Who are Thorne Healthtech's major shareholders?

Thorne Healthtech's stock is owned by a number of retail and institutional investors. Top institutional investors include Millennium Management LLC (0.94%), Emerald Mutual Fund Advisers Trust (0.87%), Emerald Advisers LLC (0.84%), Monashee Investment Management LLC (0.68%), Teacher Retirement System of Texas (0.43%) and Caas Capital Management LP (0.43%).

Which major investors are buying Thorne Healthtech stock?

THRN stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Emerald Mutual Fund Advisers Trust, Emerald Advisers LLC, Monashee Investment Management LLC, Caas Capital Management LP, Teacher Retirement System of Texas, Pura Vida Investments LLC, and MYDA Advisors LLC.

How do I buy shares of Thorne Healthtech?

Shares of THRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Thorne Healthtech's stock price today?

One share of THRN stock can currently be purchased for approximately $8.39.

How much money does Thorne Healthtech make?

Thorne Healthtech has a market capitalization of $440.85 million.

How many employees does Thorne Healthtech have?

Thorne Healthtech employs 2,021 workers across the globe.

What is Thorne Healthtech's official website?

The official website for Thorne Healthtech is www.thorne.com.

Where are Thorne Healthtech's headquarters?

Thorne Healthtech is headquartered at 152 W. 57th Street, New York NY, 10019.

How can I contact Thorne Healthtech?

Thorne Healthtech's mailing address is 152 W. 57th Street, New York NY, 10019. The company can be reached via email at [email protected].


This page was last updated on 11/29/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.